We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights NVIDIA, American Express, Wells Fargo, Elite Pharmaceuticals and PrimeEnergy
Read MoreHide Full Article
For Immediate Release
Chicago, IL – September 30, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: NVIDIA Corp., (NVDA - Free Report) , American Express Co., (AXP - Free Report) , Wells Fargo & Co. (WFC - Free Report) , Elite Pharmaceuticals, Inc. (ELTP - Free Report) and PrimeEnergy Resources Corp (PNRG - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Top Analyst Reports for NVIDIA, American Express and Wells Fargo
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp., American Express Co. and Wells Fargo & Co., as well as two micro-cap stocks Elite Pharmaceuticals, Inc. and PrimeEnergy Resources Corp. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
NVIDIA’s shares have outperformed the Zacks Semiconductor - General industry over the year-to-date period (+150.6% vs. +106.9%). The company is benefiting from the strong growth of artificial intelligence (AI), high performance and accelerated computing.
The data center end-market business is benefiting from the growing demand for generative AI and large language models using graphic processing units (GPUs) based on NVIDIA Hopper and Ampere architectures. A surge in hyperscale demand and higher sell-ins to partners across the Gaming and ProViz end markets following the normalization of channel inventory are acting as tailwinds.
Collaborations with Mercedes-Benz and Audi are likely to advance its presence in the autonomous vehicles and other automotive electronics space. However, softening IT spending amid macroeconomic headwinds and the US-China tech war remain major concerns.
Shares of American Express have outperformed the Zacks Financial - Miscellaneous Services industry over the past year (+80.9% vs. +21.8%). The company’s growth initiatives, like launching new products, reaching new agreements and forging alliances, are boosting its revenues. Consumer spending on travel and entertainment, which carries higher margins for AmEx, is advancing well.
American Express’ solid cash-generation abilities enable the pursuit of business investments and prudent deployment of capital via buybacks and dividends.
However, with higher utilization of AXP’s cards, costs in the form of card member services and card member rewards are likely to go up. Rising marketing costs are straining its margins. Its current debt level amid a high-interest rate environment induces a rise in interest expenses. The stock is overvalued at the moment. As such, the stock warrants a cautious stance.
Wells Fargo’s shares have underperformed the Banks - Major Regional industry over the past six months (-1.4% vs. +6.2%). The company’s loan growth is likely to remain limited, as the asset cap remains in place until it complies fully with regulators’ demands regarding operational risk management.
The bank agreed to divest its non-agency third-party servicing segment of the Commercial Mortgage Servicing (CMS) business to Trimont. High mortgage rates and low originations is likely to hurt mortgage banking income in the near term.
Nevertheless, its progress on efficiency initiatives, like branch and footprint reduction, will support cost reduction and drive bottom-line growth. A decent deposit balance is likely to aid its financials, driven by the strength in the Consumer Banking and Lending segment. With a strong capital position and decent liquid profile, the capital distribution seems sustainable.
Shares of Elite Pharmaceuticals have outperformed the Zacks Medical - Drugs industry over the year-to-date period (+177.9% vs. -0.5%). This microcap company with market capitalization of $415.56 million has seen first-quarter fiscal 2025 revenues surged 109.4%, driven by the success of its Elite label products.
The company’s expanding portfolio includes high-value Abbreviated New Drug Applications (ANDAs) for medications like Methotrexate and controlled substances, positioning it for continued growth. Its recent facility expansion enhances manufacturing capacity, supporting future product launches.
A robust pipeline and favorable generics market dynamics support long-term prospects. Elite Pharmaceuticals boasts positive cash flows, low debt and a solid cash position.
However, risks include customer concentration, pricing pressure from large buyers, intense competition, and regulatory challenges related to controlled substances. Supply chain vulnerabilities and potential overextension in product launches are other concerns.
PrimeEnergy Resources’ shares have outperformed the Zacks Oil and Gas - Exploration and Production - United States industry over the year-to-date period (+30.3% vs. -4.1%). This microcap company with market capitalization of $242.79 million has a strong production growth, evidenced by a 134% increase in oil and a 95% rise in natural gas production in the second quarter of 2024, positions it well for continued revenue and earnings expansion.
PrimeEnergy Resources’ financial health is supported by nearly doubling revenues and tripling net income in the first half of 2024, along with an expanded $115 million credit facility that enhances liquidity for ongoing drilling. Favorable oil prices and strategic acreage in the Permian Basin offer long-term growth potential.
However, risks include exposure to volatile oil and gas prices, rising production costs, heavy capital expenditures and dependency on a limited number of partners. The shift toward renewable energy and potential regulatory changes pose long-term risks to its traditional oil and gas operations.
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights NVIDIA, American Express, Wells Fargo, Elite Pharmaceuticals and PrimeEnergy
For Immediate Release
Chicago, IL – September 30, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: NVIDIA Corp., (NVDA - Free Report) , American Express Co., (AXP - Free Report) , Wells Fargo & Co. (WFC - Free Report) , Elite Pharmaceuticals, Inc. (ELTP - Free Report) and PrimeEnergy Resources Corp (PNRG - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Top Analyst Reports for NVIDIA, American Express and Wells Fargo
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp., American Express Co. and Wells Fargo & Co., as well as two micro-cap stocks Elite Pharmaceuticals, Inc. and PrimeEnergy Resources Corp. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
NVIDIA’s shares have outperformed the Zacks Semiconductor - General industry over the year-to-date period (+150.6% vs. +106.9%). The company is benefiting from the strong growth of artificial intelligence (AI), high performance and accelerated computing.
The data center end-market business is benefiting from the growing demand for generative AI and large language models using graphic processing units (GPUs) based on NVIDIA Hopper and Ampere architectures. A surge in hyperscale demand and higher sell-ins to partners across the Gaming and ProViz end markets following the normalization of channel inventory are acting as tailwinds.
Collaborations with Mercedes-Benz and Audi are likely to advance its presence in the autonomous vehicles and other automotive electronics space. However, softening IT spending amid macroeconomic headwinds and the US-China tech war remain major concerns.
(You can read the full research report on NVIDIA here >>>)
Shares of American Express have outperformed the Zacks Financial - Miscellaneous Services industry over the past year (+80.9% vs. +21.8%). The company’s growth initiatives, like launching new products, reaching new agreements and forging alliances, are boosting its revenues. Consumer spending on travel and entertainment, which carries higher margins for AmEx, is advancing well.
American Express’ solid cash-generation abilities enable the pursuit of business investments and prudent deployment of capital via buybacks and dividends.
However, with higher utilization of AXP’s cards, costs in the form of card member services and card member rewards are likely to go up. Rising marketing costs are straining its margins. Its current debt level amid a high-interest rate environment induces a rise in interest expenses. The stock is overvalued at the moment. As such, the stock warrants a cautious stance.
(You can read the full research report on American Express here >>>)
Wells Fargo’s shares have underperformed the Banks - Major Regional industry over the past six months (-1.4% vs. +6.2%). The company’s loan growth is likely to remain limited, as the asset cap remains in place until it complies fully with regulators’ demands regarding operational risk management.
The bank agreed to divest its non-agency third-party servicing segment of the Commercial Mortgage Servicing (CMS) business to Trimont. High mortgage rates and low originations is likely to hurt mortgage banking income in the near term.
Nevertheless, its progress on efficiency initiatives, like branch and footprint reduction, will support cost reduction and drive bottom-line growth. A decent deposit balance is likely to aid its financials, driven by the strength in the Consumer Banking and Lending segment. With a strong capital position and decent liquid profile, the capital distribution seems sustainable.
(You can read the full research report on Wells Fargo here >>>)
Shares of Elite Pharmaceuticals have outperformed the Zacks Medical - Drugs industry over the year-to-date period (+177.9% vs. -0.5%). This microcap company with market capitalization of $415.56 million has seen first-quarter fiscal 2025 revenues surged 109.4%, driven by the success of its Elite label products.
The company’s expanding portfolio includes high-value Abbreviated New Drug Applications (ANDAs) for medications like Methotrexate and controlled substances, positioning it for continued growth. Its recent facility expansion enhances manufacturing capacity, supporting future product launches.
A robust pipeline and favorable generics market dynamics support long-term prospects. Elite Pharmaceuticals boasts positive cash flows, low debt and a solid cash position.
However, risks include customer concentration, pricing pressure from large buyers, intense competition, and regulatory challenges related to controlled substances. Supply chain vulnerabilities and potential overextension in product launches are other concerns.
(You can read the full research report on Elite Pharmaceuticals here >>>)
PrimeEnergy Resources’ shares have outperformed the Zacks Oil and Gas - Exploration and Production - United States industry over the year-to-date period (+30.3% vs. -4.1%). This microcap company with market capitalization of $242.79 million has a strong production growth, evidenced by a 134% increase in oil and a 95% rise in natural gas production in the second quarter of 2024, positions it well for continued revenue and earnings expansion.
PrimeEnergy Resources’ financial health is supported by nearly doubling revenues and tripling net income in the first half of 2024, along with an expanded $115 million credit facility that enhances liquidity for ongoing drilling. Favorable oil prices and strategic acreage in the Permian Basin offer long-term growth potential.
However, risks include exposure to volatile oil and gas prices, rising production costs, heavy capital expenditures and dependency on a limited number of partners. The shift toward renewable energy and potential regulatory changes pose long-term risks to its traditional oil and gas operations.
(You can read the full research report on PrimeEnergy Resources here >>>)
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.